Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Novel Cardiac Biopsy Scoring Tool to Predict Clinical Outcomes in Cardiac Light Chain (AL) Amyloidosis

Ujjawal H Gandhi, PhDMBBS, Hanna Von Haefen, Robert Hoffman, MD PhD, Alexandra Ritts, MD, Sharon Phillips, MSPH, Oluchi Ukaegbu, MD, Samuel Rubinstein, MD, Shelton Lacy Harrell, MSN, Stacey A. Goodman, MD MS, Daniel Lenihan, MD, David Slosky, MD, Rebecca Hung, MD PhD, Robert Frank Cornell, MD

Blood (2017) 130 (Supplement 1): 1881.

https://doi.org/10.1182/blood.V130.Suppl_1.1881.1881

Published: 2017

Journal Articles

Pulmonary Hypertension Independently Shortens Survival of Patients with Myeloproliferative Neoplasms

Jiwon Kim, MD, Spencer Krichevsky, BS, Neil K Mehta, MD, Sara Rodriguez-Diego, MD, Meridith P Pollie, BS, Richard T Silver, MD, Andrew I Schafer, MD, Ellen K Ritchie, MD, Mia Wiese, BS, Claudia Sosner, BA, Evelyn M Horn, MD, Richard B Devereux, MD, Jonathan W Weinsaft, MD, Joseph Scandura, MDPhD

Blood (2017) 130 (Supplement 1): 324.

https://doi.org/10.1182/blood.V130.Suppl_1.324.324

Published: 2017

Journal Articles

99m Technetium-Hydroxy-Diphosphate Tracer (99mTcHDP) Bone Scintigraphy: An Easily Accessible, Rapid, Non-Invasive Diagnostic Tool for Cardiac Amyloidosis

Simon DJ Gibbs, MBBS, FRACP, FRCPA, Caroline Wong, MBBS, James Hare, MBBS FRACP, Hendrik Zimmet, MBBS FRACP, Jay Hocking, MBBS, FRACP, FRCPA, Anthony P Schwarer, MD MBBS (Hons), FRACP, FRCPA, Stephen B Ting, MB BS, FRACP, FRCPA, PhD

Blood (2016) 128 (22): 3557.

https://doi.org/10.1182/blood.V128.22.3557.3557

Published: 2016

Journal Articles

Predictors of Survival in De Novo Cardiac Amyloidosis.

Raymond L. Comenzo, MD, Mathew Maurer, MD, Adam Cohen, MD, Hani Hassoun, MD, Ping Zhou, PhD, Ping Lu, PhD, Martin Fleisher, PhD, Daniel Lebovic, MD, Julie Feldstein, MD, Richard Steingart, MD, Stephen D. Nimer, MD

Blood (2007) 110 (11): 2870.

https://doi.org/10.1182/blood.V110.11.2870.2870

Published: 2007

Journal Articles

Long Term Efficacy of Rituximab in B-Cell Post Transplantation Lymphoproliferative Disorders (B-PTLD): Update of the Multicenter, Open Label, Phase II Trial (M39037 TRIAL).

Sylvain Choquet, MD, Raoul Herbrecht, MD, Anne-marie Stoppa, MD, Peter Vandenberghe, MD, Walter Feremans, MD, Franck Morschhauser, MD, Gilles Andre Salles, MD, Arnaud Jaccard, MD, Thierry Lamy, MD, Yves Lebranchu, MD, Philippe Offner, MD, Eric Oksenhendler, MD, Martine Raphael, MD, Veronique Leblond, MD, Noel-Jean Milpied, MD

Blood (2006) 108 (11): 2764.

https://doi.org/10.1182/blood.V108.11.2764.2764

Published: 2006

Journal Articles

Cardiac MRI (T2,T2*) Predicts Cardiac Iron in the Gerbil Model of Iron Cardiomyopathy.

John C. Wood, MD, PhD, Maya Otto-Duessel, MS, Michelle Aguilar, BS, Hanspeter Nick, PhD, Marvin D. Nelson, MD, Thomas D. Coates, MD, Rex Moats, PhD

Blood (2004) 104 (11): 376.

https://doi.org/10.1182/blood.V104.11.376.376

Published: 2004

NARROW

Novel Cardiac Biopsy Scoring Tool to Predict Clinical Outcomes in Cardiac Light Chain (AL) Amyloidosis

Pulmonary Hypertension Independently Shortens Survival of Patients with Myeloproliferative Neoplasms

99m Technetium-Hydroxy-Diphosphate Tracer (99mTcHDP) Bone Scintigraphy: An Easily Accessible, Rapid, Non-Invasive Diagnostic Tool for Cardiac Amyloidosis

Predictors of Survival in De Novo Cardiac Amyloidosis.

Long Term Efficacy of Rituximab in B-Cell Post Transplantation Lymphoproliferative Disorders (B-PTLD): Update of the Multicenter, Open Label, Phase II Trial (M39037 TRIAL).

Cardiac MRI (T2,T2*) Predicts Cardiac Iron in the Gerbil Model of Iron Cardiomyopathy.

Email alerts

ASH Publications

American Society of Hematology

Novel Cardiac Biopsy Scoring Tool to Predict Clinical Outcomes in Cardiac Light Chain (AL) Amyloidosis

Pulmonary Hypertension Independently Shortens Survival of Patients with Myeloproliferative Neoplasms

99m Technetium-Hydroxy-Diphosphate Tracer (99mTcHDP) Bone Scintigraphy: An Easily Accessible, Rapid, Non-Invasive Diagnostic Tool for Cardiac Amyloidosis

Predictors of Survival in De Novo Cardiac Amyloidosis.

Long Term Efficacy of Rituximab in B-Cell Post Transplantation Lymphoproliferative Disorders (B-PTLD): Update of the Multicenter, Open Label, Phase II Trial (M39037 TRIAL).

Cardiac MRI (T2,T2*) Predicts Cardiac Iron in the Gerbil Model of Iron Cardiomyopathy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only